Thalia Therapeutics Plc (AIM: THAT)
Health Care · Pharmaceuticals · GB
£0.01
+0.00% today · +52.9% 1Y
Thalia Therapeutics Plc (AIM: THAT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $7.37M.
Over the last twelve months the share price has gained 52.9%, trading between 0.00 and 0.01.
Tweenvest scores Thalia Therapeutics Plc across four factors: quality 29/100, value 68/100. Its strongest factor is value.
THAT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.37M
- Revenue (TTM)
- $9.78K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.72
- 52-week high
- £0.01
- 52-week low
- £0.00
- Avg volume (3M)
- —
- Shares outstanding
- 832.28M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,235.16 | +0.12% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | 0.00% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.27 | -0.12% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.70 | -0.03% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.52 | -0.99% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.